TROY, Mich., Nov. 13, 2024 /PRNewswire/ -- NICE's recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine considers NICE (NICE:Nasdaq) as worthy of further study and has named NICE its "Stock to Study" for the January/February 2025 double issue for investors' informational and educational use.The fundamental data is eye-opening; investors can view NICE's sales, earnings, ...